Structural modification of the Cas9 protein produces higher fidelity variants, such as SpCas9-HF1, eSpCas9, which are more precise in AD-related gene editing and more effective in correcting disease-causing variant mutations with less interference with non-target genes (Guo et al., 2019). The gene discussed is CFH; the disease is Alzheimer disease.